Positive Results from Waldenstrom’s Macroglobulinemia Treatment Trial Means it will Continue

According to a recent article, the trial studying the success of CLR 131 to treat Waldenstrom’s macroglobulinemia has shown promising results, allowing it to continue. Waldenstrom Macroglobulinemia (WM) Waldenstrom macroglobulinemia…

Continue Reading Positive Results from Waldenstrom’s Macroglobulinemia Treatment Trial Means it will Continue
Second-Ever Therapy for Waldenström’s Macroglobulinemia is Now FDA Approved
source: pixabay.com

Second-Ever Therapy for Waldenström’s Macroglobulinemia is Now FDA Approved

The FDA has just announced their approval of zanubrutinib (Brukinsa) as a therapeutic option for Waldenström's macroglobulinemia. This approval was given based on the ASPEN Phase 3 clinical trial, and…

Continue Reading Second-Ever Therapy for Waldenström’s Macroglobulinemia is Now FDA Approved
Waldenström’s Macroglobulinemia Precursor States: Could They be Key to a Cure?
source: pixabay.com

Waldenström’s Macroglobulinemia Precursor States: Could They be Key to a Cure?

On October 14th, 2020, the International Waldenström's Macroglobulinemia Foundation (IWMF) hosted a webinar featuring Dr. Irene Ghobrial of the Dana Farber Cancer Institute. The focus of her presentation was on…

Continue Reading Waldenström’s Macroglobulinemia Precursor States: Could They be Key to a Cure?
September 15th is World Lymphoma Awareness Day: Spreading Blood Cancer Awareness
source: pixabay.com

September 15th is World Lymphoma Awareness Day: Spreading Blood Cancer Awareness

September 15th, 2020 is recognized as World Lymphoma Awareness Day. This day is dedicated to spreading awareness about lymphoma and falls in the context of Blood Cancer Awareness Month, which…

Continue Reading September 15th is World Lymphoma Awareness Day: Spreading Blood Cancer Awareness
Investigational Waldenström’s Macroglobulinemia Treatment Earns Orphan Drug Designation
source: pixabay.com

Investigational Waldenström’s Macroglobulinemia Treatment Earns Orphan Drug Designation

According to a story from BioSpace, the biotechnology company Ascentage Pharma has just announced that it has been given Orphan Drug designation from the US Food and Drug Administration (FDA).…

Continue Reading Investigational Waldenström’s Macroglobulinemia Treatment Earns Orphan Drug Designation